Cystic Fibrosis - Insulin Deficiency, Early Action

Trial Profile

Cystic Fibrosis - Insulin Deficiency, Early Action

Phase of Trial: Phase III

Latest Information Update: 09 Oct 2017

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms CF-IDEA
  • Most Recent Events

    • 03 Oct 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2019.
    • 03 Oct 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2018.
    • 10 Jun 2017 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top